logo
Aldi, Tesco and Sainsbury's to introduce major change to store layouts

Aldi, Tesco and Sainsbury's to introduce major change to store layouts

Daily Mail​6 hours ago
Supermarkets will reportedly be required to make significant changes to their stores as part of a government crackdown on obesity. The Government plans to introduce a health food standard for supermarkets to make the average shopping basket 'slightly healthier' and ease pressure on the NHS.
Public health experts say that cutting 50 calories a day would lift 340,000 children and 2 million adults out of obesity, which is one of the root causes of diabetes , heart disease and cancer . Major supermarkets will have to report on healthy food sales and 'increase the healthiness of sales in communities across the UK', according to the Department of Health and Social Care.
This means that they may have to reformulate products, change the layout of stores, offer discounts on healthy foods, or change loyalty schemes to promote healthier options. Wes Streeting , health and social care secretary said: 'Our brilliant supermarkets already do so much work for our communities and are trying to make their stores healthier, and we want to work with them and other businesses to create a level playing field.
'Through our new healthy food standard, we will make the healthy choice the easy choice, because prevention is better than cure.' He told Sky News that the plans were not 'nanny statism' but a 'world-first approach'. The health department said that many supermarkets 'want to do more to make the average shopping basket healthier, but they risk changes hitting their bottom lines if their competitors don't act at the same time.
'The new standard will introduce a level playing field, so there isn't a first mover disadvantage.' It is the latest attempt by central government to push supermarkets into promoting healthy food. In 2022, supermarkets were banned from displaying products high in fat, salt and sugar in shop entrances and till areas.
A ban on junk food adverts targeting children, which was due to be introduced in October, is set to be delayed until next year. Research by Which? Shows that three in five consumers said they support the Government introduced health targets for supermarkets.
Some of the UK's biggest supermarkets have welcomed the announcement Ken Murphy, Tesco chief executive, said the supermarket giant had called for 'mandatory reporting for all supermarkets and major food businesses and why we welcome the Government's announcement on this. 'We look forward to working with them on the detail of the Healthy Food Standard and its implementation by all relevant food businesses.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Alcohol advertising ban dropped after industry backlash
Alcohol advertising ban dropped after industry backlash

Times

time15 minutes ago

  • Times

Alcohol advertising ban dropped after industry backlash

A planned ban on alcohol advertising has been dropped after a backlash from industry. Public health measures considered for inclusion in the government's ten-year plan for the NHS have been left out after pushback from Treasury and business ministers concerned about the impact on the economy. Tougher health warnings telling drinkers that alcohol causes cancer are being considered, but there is unlikely to be a blanket requirement for them to be carried on bottles. Ministers have considered a model in Ireland, where alcohol packaging will soon be required to carry labelling warning of a 'direct link between alcohol and fatal cancers'. The plan is expected to include suggestions for exploring such a policy. Health officials had originally hoped to include a minimum unit price for alcohol in the plan, importing a Scottish policy that means a pint of beer cannot be sold for less than about £1.50 or a bottle of vodka for less than £20. However, this was vetoed at an early stage, while alcohol advertising restrictions remained in play. This could have been either a total ban or a 9pm watershed designed to bring alcohol into line with rules being introduced this year for unhealthy food. The Times understands that alcohol advertising restrictions have now been dropped from the plan to be published on Thursday after public health measures were watered down. • Restaurants to report diners' calorie counts in obesity drive The development followed a furious response from the industry, which urged ministers not to add to burdens after a rise in national insurance and the minimum wage. Emma McClarkin, chief executive of the British Beer and Pub Association, told ministers of 'extreme concern' in the industry, criticising advertising restrictions as 'disproportionate, misguided and economically damaging' and warning they could lead to bankruptcies. She pointed to figures showing under-age drinking at record lows as young people turned away from alcohol. 'The beer and pub sector is not just an economic engine — it is a cornerstone of British culture and sport,' McClarkin said. 'These proposals were not included in the Labour Party's 2024 manifesto and risk being widely perceived as anti-growth and anti-business.' Health campaigners condemned the retreat on advertising restrictions. Jem Roberts of the Institute of Alcohol Studies said: 'One of the main goals of the ten-year health plan was to 'shift from treatment to prevention' — yet if reports are accurate, all of the prevention policies for one of the leading causes of death have been stripped out. 'That would be a baffling contradiction at the heart of a plan meant to prioritise prevention.' He said 'alcohol giants making billions from harm will be rubbing their hands in glee', adding: 'Ministers must now stand up to private corporate profits, protect the most vulnerable and, if alcohol is too 'difficult' for the ten-year plan, commit to a standalone alcohol strategy where all evidence is reviewed and all cards put openly on the table.' Campaigners have been warning of a rise in alcohol deaths. More than 10,000 people a year die directly from alcohol in the UK and deaths in England are at record highs. Thousands more cancer deaths are thought to be attributable to alcohol. Treatment costs the NHS at least £3.5 billion a year.

SNP has left NHS fighting for its life as one in 10 operations are still being cancelled
SNP has left NHS fighting for its life as one in 10 operations are still being cancelled

Daily Mail​

timean hour ago

  • Daily Mail​

SNP has left NHS fighting for its life as one in 10 operations are still being cancelled

Scotland's NHS is 'dangerously flatlining' despite SNP promises to improve performance with almost one in 10 planned operations still being cancelled. Despite a pledge from John Swinney and his under-fire Health Secretary Neil Gray to 'renew' the NHS, new figures showed a decline in the number of planned operations in May compared to a year ago, while the number of them being cancelled has marginally increased. It led to concerns about the impact cancellations have on the physical and mental health of patients. Cases of patients being stuck in hospital because of bed-blocking were also similar in May compared to April, data from Public Health Scotland showed, sparking claims that the SNP Government has failed to deliver the improvements it has promised. Scottish Conservative public health spokesman Brian Whittle said: 'These figures confirm that our NHS is dangerously flatlining under Neil Gray and John Swinney's disastrous stewardship. 'Having an operation cancelled at the last minute takes a huge toll on the physical and mental wellbeing of patients. 'The reason the number of cancelled operations remains so stubbornly high is almost two decades of SNP mismanagement. From years of shoddy workforce planning to the knock-on effects of their failure to eliminate bed-blocking, Scots are paying the price for Nationalist incompetence.' The new Public Health Scotland figures showed that there were 25,067 operations planned to take place across the NHS in Scotland in May 2025, which was 311 lower than May 2024. The numbers had previously been steadily increasing since the coronavirus pandemic but 'began to plateau' from April 2024. In the period from June 2024 to May 2025 there was a 0.6 per cent increase compared to the previous 12 month period, but this was 14.6 per cent lower than the last full pre-Covid year in 2018/19. Public Health Scotland's report said: 'While a year-on-year increase is still being observed, the rate of growth has slowed.' In May 2025, 2,019, or 8.1 per cent, of all planned operations were cancelled, compared to 2,018, or 8 per cent, in May 2024. In three health boards, the rate of cancellations was well above one in ten, with 12.1 per cent in NHS Orkney, 10.5 per cent in NHS Dumfries and Galloway and 10.3 per cent in NHS Borders. Of those appointments cancelled, 437 did not go ahead because of hospital capacity or other non-clinical reasons. Scottish Labour health spokesman Jackie Baillie said: 'At a time when thousands of Scots are languishing on waiting lists waiting for treatment, it is a scandal that fewer operations are taking place. 'Far from tackling the crisis in our NHS, the SNP is fanning its flames.' Figures also showed bed-blocking - where patients are medically well enough to be discharged but are stuck in hospital because they do not have a care home place or an agreed care plan - remains a significant strain on the NHS. The number of these 'delayed discharge' cases was 1,840 in May 2025, compared to 1,868 in March 2025. An average of 1,852 beds were occupied per day because of delayed discharge in May, which is only a marginal decline on 1,864 in April. Dr Fiona Hunter, vice president of the Royal College of Emergency Medicine Scotland, said: 'Yet again, the evidence to address delayed discharges continues to mount. As I've said before, and I will say it again, the situation at our hospitals' 'backdoor', where we are unable to discharge people, is deeply concerning and distressing for both patients and the workforce. 'Patients when they are well enough to leave want to do just that - leave to continue their recovery. But often they can't because of a lack of social care.' She said 'seriously unwell people' in A&E are often left on trolleys waiting for a care bed, and added: 'So it is hard to celebrate slight improvements in extreme waiting times when every day my colleagues are struggling to admit vulnerable patients that need further care. 'Until available inpatient bed numbers increase the crisis in our EDs will continue.' Health Secretary Mr Gray said: 'Despite continued pressure on our health service it is encouraging to see an increase in the number of planned operations in the last year, compared to the previous twelve months. 'We are working closely with health boards across Scotland to maximise capacity and to ensure that any patients who have had their operations cancelled are seen as quickly as possible. 'Through an additional £200 million investment contained in the Budget to reduce waiting times and improve flow through hospital, we are creating extra appointments and procedures while making greater use of regional and national working.' On delayed discharge, he said: 'Alongside recent improvements in A&E waiting times, this latest data shows our efforts are working and our plan is delivering results. 'But we want to drive further improvements, which is why we are investing £200 million through our Budget to reduce waiting lists, expand capacity, and remove the barriers that keep patients in hospital longer than necessary - backed by a record £21 billion investment for Health and Social Care.'

AstraZeneca boss ‘wants to shift stock market listing to US'
AstraZeneca boss ‘wants to shift stock market listing to US'

The Guardian

timean hour ago

  • The Guardian

AstraZeneca boss ‘wants to shift stock market listing to US'

AstraZeneca's chief executive, Pascal Soriot, has reportedly said that he would like to shift the company's stock market listing from the UK to the US. The boss of Britain's most valuable listed company has spoken privately about a preference to move the listing to New York, the Times reported. It added that he had also considered moving the company's domicile. The FTSE 100 company's share price rose by 2.8% on Tuesday, with most of the increase happening after the story was published. A shift in AstraZeneca's listing would deal a major blow to the London Stock Exchange, which has already had to deal with a series of departures by companies seeking higher valuations. Among those who have left the FTSE 100 in recent years are equipment rental company Ashtead, Paddy Power bookmaker owner Flutter Entertainment, building materials supplier CRH and packaging company Smurfit Westrock. A shift by AstraZeneca would almost certainly face opposition by the UK government, although it would not have the power to formally block a move. Labour made life sciences one of its key growth sectors in its industrial strategy published last month. A spokesperson for AstraZeneca declined to comment. The government remains stuck in negotiations with the drug industry, including AstraZeneca, over rebates that pharmaceutical companies must pay on sales of new medicines to the NHS, under a voluntary agreement. Soriot has publicly expressed his frustration over the rejection of AstraZeneca'sbreast cancer drug Enhertu for use in the NHS on cost grounds. Earlier this year, the company, headquartered in Cambridge, caused consternation in government by pulling out of a £450m project to produce vaccines in Speke, Liverpool, while saying that the business case did not make sense without more financial support from government. Soriot has overseen the market value of AstraZeneca more than tripling since he took over in October 2012. The company has overtaken oil company Shell – also seen as a contender for a move to the US – and HSBC, a bank, with a market value of £157bn. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion The US is the world's biggest pharmaceutical market, with by far the highest spending per person on medicines despite having a lower life expectancy than several other countries. UK executives have long complained that their companies are undervalued compared with American counterparts. Soriot has emphasised the company's ambitions to grow in the US. In November, he told investors that 'we want to see even more growth in the US over the next few years as part of our 2030 ambition,' according to a transcript from data company Alphasense. The 'US is, of course, a very important market and that supports innovation, and we will continue to invest to grow fast in this part of the world', Soriot said. The chief executive's pay has increased in line with AstraZeneca's market value. He has been the highest-paid chief executive on the FTSE 100 for two years running, receiving £16.85m for 2023, up from £15.3m in 2022.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store